...
首页> 外文期刊>Human vaccines & immunotherapeutics. >Trends in classifying vaccine hesitancy reasons reported in the WHO/UNICEF Joint Reporting Form, 2014-2017: Use and comparability of the Vaccine Hesitancy Matrix
【24h】

Trends in classifying vaccine hesitancy reasons reported in the WHO/UNICEF Joint Reporting Form, 2014-2017: Use and comparability of the Vaccine Hesitancy Matrix

机译:分类疫苗犹豫不决原因的趋势在世界卫生组织/儿童基金会联合报告表中报告,2014-2017:疫苗犹豫不决矩阵的使用和可比性

获取原文
获取原文并翻译 | 示例

摘要

Since 2014, the World Health Organization (WHO) member states have been annually reporting vaccine hesitancy reasons, using the WHO/UNICEF Joint Reporting Form (JRF). The Vaccine Hesitancy Matrix (VHM), developed by a WHO strategic advisory group of experts, can serve as an important tool to categorize vaccine hesitancy reasons reported in the JRF. We aimed to describe the reasons for vaccine hesitancy reported globally from 2014 to 2017 to ascertain trends over time and understand the comparability of using the VHM to classify hesitancy reasons from 2014 to 2016 based on previously published literature. We conducted a quantitative content analysis to code and categorize vaccine hesitancy reasons reported in the JRF from 2014 to 2017. Vaccine hesitancy trends were consistent from 2014 to 2017, where vaccine hesitancy reasons were mainly related to "individual and group level influences" (59%) followed by "contextual influences" (25%), and "vaccine- or vaccination-specific issues" (16%). Comparability of our approach to categorize vaccine hesitancy to the previously published JRF data showed that results were mostly but not entirely consistent. Major differences in categorizing vaccine hesitancy were noted between two specific reasons - "experience with past vaccination" (under "individual and group influences") and "risk/benefit- scientific evidence" (under "vaccine and vaccination-specific issues"); this was usually due to lack of clear definitions in some sub-categories and generic responses reported in the JRF. The JRF hesitancy module may benefit from modifications to improve the data quality. Understanding global vaccine hesitancy is crucial and JRF can serve as an important tool, especially with the potential introduction of a COVID-19 vaccine.
机译:自2014年以来,世界卫生组织(世卫组织)成员国每年都使用世卫组织/联合国儿童基金会联合报告表(JRF)报告疫苗犹豫不决的原因。世卫组织战略咨询专家组开发的疫苗犹豫不决矩阵(VHM)可以作为一个重要工具,对JRF报告的疫苗犹豫不决原因进行分类。我们的目的是描述2014年至2017年全球报告的疫苗犹豫不决的原因,以确定一段时间内的趋势,并了解根据之前发表的文献,使用VHM对2014年至2016年的犹豫不决原因进行分类的可比性。我们进行了定量内容分析,对2014年至2017年JRF中报告的疫苗犹豫不决原因进行编码和分类。2014年至2017年,疫苗犹豫不决的趋势是一致的,其中疫苗犹豫不决的原因主要与“个人和群体层面的影响”(59%)有关,其次是“背景影响”(25%)和“疫苗或疫苗特定问题”(16%)。我们对疫苗犹豫不决进行分类的方法与之前公布的JRF数据的可比性表明,结果基本一致,但并不完全一致。在对疫苗犹豫不决进行分类时,注意到两个具体原因之间的主要差异——“过去接种疫苗的经验”(在“个人和群体影响”下)和“风险/收益-科学证据”(在“疫苗和接种特定问题”下);这通常是由于在一些子类别中缺乏明确的定义,以及JRF中报告的一般回复。JRF犹豫不决模块可以通过修改来提高数据质量。了解全球疫苗2019冠状病毒疾病是至关重要的,JRF可以作为一个重要的工具,特别是潜在的引入CVID-19疫苗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号